Last updated on February 2020

A Clinical Trial to Demonstrate the Effectiveness and Safety of Liposomal Cyclosporine A Inhalation Solution in the Treatment of Bronchiolitis Obliterans Syndrome in Patients Post Double Lung Transplant


Brief description of study

This is a Phase III randomized, controlled clinical trial of L-CsA for the treatment of bronchiolitis obliterans syndrome in adults diagnosed with BOS following double lung transplant. Patients will receive either L-CsA (10 mg) via the PARI Investigational eFlow Device twice daily plus Standard of Care (SoC) treatment, or SoC alone, for a period of 48 weeks. All patients will be eligible to continue in an open-label extension trial of L-CsA following completion of BOSTON-2.

Detailed Study Description

Regardless of treatment allocation, all patients will continue to receive their SoC regimen for maintenance of the lung allograft. Eligible patients for the clinical trial must have a tacrolimus-based triple-drug therapy in combination with mycophenolate mofetil or its equivalent and a corticosteroid.

A total of 11 visits will be performed during the clinical trial. After informed consent has been obtained, a Screening Visit will be carried out in order to check general eligibility for participation. At the Randomization Visit, inclusion and exclusion criteria will be re-checked and spirometry performed. During the 48-week treatment period, visits are scheduled every 4-8 weeks. If a patient has an event that meets one of the criteria for progression of BOS, he/she will return to the clinic within 2-weeks for an unscheduled visit to have spirometry and other procedures performed.

Clinical Study Identifier: NCT03656926

Find a site near you

Start Over

St. Joseph's Hospital

Phoenix, AZ United States
  Connect »

UCLA Medical Center

Los Angeles, CA United States
  Connect »

Stanford University Hospital

Palo Alto, CA United States
  Connect »

UC San Francisco

San Francisco, CA United States
  Connect »

Mayo Clinic Jacksonville

Jacksonville, FL United States
  Connect »

Indiana University

Indianapolis, IN United States
  Connect »

University of Maryland

Baltimore, MD United States
  Connect »

Barnes Jewish Hospital

Saint Louis, MO United States
  Connect »

Cleveland Clinic

Cleveland, OH United States
  Connect »

University of Pennsylvania

Philadelphia, PA United States
  Connect »

Temple University Hospital

Philadelphia, PA United States
  Connect »

Houston Methodist Hospital

Houston, TX United States
  Connect »

Inova Hospital

Falls Church, VA United States
  Connect »

CHU Erasme

Brussels, Belgium
  Connect »

Royal Papworth Hospital

Cambridge, United Kingdom
  Connect »

University of Manchester

Manchester, United Kingdom
  Connect »

Banner Health

Phoenix, AZ United States
  Connect »